Subang Jaya Medical Centre is the first hospital in Malaysia to publish next-generation sequencing data in lung cancer, setting new standards in personalised treatment.
Rapid in-house next-generation sequencing (NGS) testing in hospitals enables fast, actionable results in days instead of weeks (1). This allows timely initiation of targeted therapy for cancer, improving patient outcomes and potentially translating into higher survival rates.
Over 250 distinguished experts and leaders from the medical, health care, and academic sectors attended the 1st Malaysia Pharmacogenomics Summit 2024, a significant milestone in advancing precision medicine and pharmacogenomics across the Asia Pacific.